188 related articles for article (PubMed ID: 21986871)
1. Clozapine, but not olanzapine, disrupts conditioned avoidance response in rats by antagonizing 5-HT2A/2C receptors.
Li M; Sun T; Mead A
J Neural Transm (Vienna); 2012 Apr; 119(4):497-505. PubMed ID: 21986871
[TBL] [Abstract][Full Text] [Related]
2. Distinct neural mechanisms underlying acute and repeated administration of antipsychotic drugs in rat avoidance conditioning.
Li M; Sun T; Zhang C; Hu G
Psychopharmacology (Berl); 2010 Sep; 212(1):45-57. PubMed ID: 20623111
[TBL] [Abstract][Full Text] [Related]
3. Effects of central activation of serotonin 5-HT2A/2C or dopamine D 2/3 receptors on the acute and repeated effects of clozapine in the conditioned avoidance response test.
Feng M; Gao J; Sui N; Li M
Psychopharmacology (Berl); 2015 Apr; 232(7):1219-30. PubMed ID: 25288514
[TBL] [Abstract][Full Text] [Related]
4. Long-term impacts of adolescent risperidone treatment on behavioral responsiveness to olanzapine and clozapine in adulthood.
Qiao J; Zhang Q; Li M
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():177-85. PubMed ID: 24140929
[TBL] [Abstract][Full Text] [Related]
5. Repeated asenapine treatment produces a sensitization effect in two preclinical tests of antipsychotic activity.
Qin R; Chen Y; Li M
Neuropharmacology; 2013 Dec; 75():356-64. PubMed ID: 23954676
[TBL] [Abstract][Full Text] [Related]
6. Olanzapine and risperidone disrupt conditioned avoidance responding in phencyclidine-pretreated or amphetamine-pretreated rats by selectively weakening motivational salience of conditioned stimulus.
Li M; He W; Mead A
Behav Pharmacol; 2009 Feb; 20(1):84-98. PubMed ID: 19179852
[TBL] [Abstract][Full Text] [Related]
7. Olanzapine sensitization and clozapine tolerance: from adolescence to adulthood in the conditioned avoidance response model.
Qiao J; Li H; Li M
Neuropsychopharmacology; 2013 Feb; 38(3):513-24. PubMed ID: 23132270
[TBL] [Abstract][Full Text] [Related]
8. Time-dependent sensitization of antipsychotic effect in adolescent male and female rats.
Ding X; Li X; Shu Q; Wu R; Hu G; Li M
Behav Brain Res; 2017 Jun; 328():186-194. PubMed ID: 28412306
[TBL] [Abstract][Full Text] [Related]
9. Olanzapine and risperidone disrupt conditioned avoidance responding by selectively weakening motivational salience of conditioned stimulus: further evidence.
Zhang C; Fang Y; Li M
Pharmacol Biochem Behav; 2011 Mar; 98(1):155-60. PubMed ID: 21194545
[TBL] [Abstract][Full Text] [Related]
10. The receptor mechanisms underlying the disruptive effects of haloperidol and clozapine on rat maternal behavior: a double dissociation between dopamine D(2) and 5-HT(2A/2C) receptors.
Zhao C; Li M
Pharmacol Biochem Behav; 2009 Oct; 93(4):433-42. PubMed ID: 19539643
[TBL] [Abstract][Full Text] [Related]
11. Avoidance disruptive effect of clozapine and olanzapine is potentiated by increasing the test trials: further test of the motivational salience hypothesis.
Feng M; Sui N; Li M
Pharmacol Biochem Behav; 2013 Jan; 103(3):467-73. PubMed ID: 23026062
[TBL] [Abstract][Full Text] [Related]
12. Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice.
Gleason SD; Shannon HE
Psychopharmacology (Berl); 1997 Jan; 129(1):79-84. PubMed ID: 9122367
[TBL] [Abstract][Full Text] [Related]
13. Adult response to olanzapine or clozapine treatment is altered by adolescent antipsychotic exposure: a preclinical test in the phencyclidine hyperlocomotion model.
Shu Q; Hu G; Li M
J Psychopharmacol; 2014 Apr; 28(4):363-75. PubMed ID: 24257809
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of latent inhibition by two 5-HT2A receptor antagonists only when given at both pre-exposure and conditioning.
McDonald LM; Moran PM; Vythelingum GN; Joseph MH; Stephenson JD; Gray JA
Psychopharmacology (Berl); 2003 Sep; 169(3-4):321-31. PubMed ID: 14530903
[TBL] [Abstract][Full Text] [Related]
15. Antagonist functional selectivity: 5-HT2A serotonin receptor antagonists differentially regulate 5-HT2A receptor protein level in vivo.
Yadav PN; Kroeze WK; Farrell MS; Roth BL
J Pharmacol Exp Ther; 2011 Oct; 339(1):99-105. PubMed ID: 21737536
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the novel antipsychotic ziprasidone with clozapine and olanzapine: inhibition of dorsal raphe cell firing and the role of 5-HT1A receptor activation.
Sprouse JS; Reynolds LS; Braselton JP; Rollema H; Zorn SH
Neuropsychopharmacology; 1999 Nov; 21(5):622-31. PubMed ID: 10516958
[TBL] [Abstract][Full Text] [Related]
17. A drug-drug conditioning paradigm reveals multiple antipsychotic-nicotine interactions.
Feng M; Sparkman NL; Sui N; Li M
J Psychopharmacol; 2017 Apr; 31(4):474-486. PubMed ID: 28347260
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of olanzapine, risperidone, and quetiapine on serotonin 1A, 2A and 2C receptors in rat forebrain regions.
Tarazi FI; Zhang K; Baldessarini RJ
Psychopharmacology (Berl); 2002 May; 161(3):263-70. PubMed ID: 12021829
[TBL] [Abstract][Full Text] [Related]
19. Continuous oral olanzapine or clozapine treatment initiated in adolescence has differential short- and long-term impacts on antipsychotic sensitivity than those initiated in adulthood.
Wu R; Chou S; Li M
Eur J Pharmacol; 2024 Jun; 972():176567. PubMed ID: 38582275
[TBL] [Abstract][Full Text] [Related]
20. Antagonism at 5-HT(2A) receptors potentiates the effect of haloperidol in a conditioned avoidance response task in rats.
Wadenberg MG; Browning JL; Young KA; Hicks PB
Pharmacol Biochem Behav; 2001 Mar; 68(3):363-70. PubMed ID: 11325387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]